Clinical Trial Update: Window of Opportunity Study of DSP-0390 in Gliomas [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 window-of-opportunity trial of DSP-0390 in malignant gliomas with IDH mutation is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idh-mutant Glioma
• Malignant Glioma

Drugs mentioned

• DSP-0390

Snippet

Sponsor: Washington University School of Medicine | Conditions: Glioma, Malignant, IDH Mutation | EARLY_Phase 1 | Status: RECRUITING